UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of gastric pH on the pharmacokinetics of a bcs class II compound in dogs: Utilization of an artificial stomach and duodenum dissolution model and gastroplus,™ simulations to predict absorption

Journal of pharmaceutical sciences, 2011-11, Vol.100 (11), p.4756-4765

2011

Volltextzugriff (PDF)

Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor

ACS medicinal chemistry letters, 2011-02, Vol.2 (2), p.91-96

2011

Volltextzugriff (PDF)

Weak bases and formation of a less soluble lauryl sulfate salt/complex in sodium lauryl sulfate (SLS) containing media

International journal of pharmaceutics, 2011-06, Vol.412 (1), p.95-98

2011

Volltextzugriff (PDF)

769-P: Effect of Food on the Pharmacokinetics, Safety, and Tolerability of Orforglipron (LY3502970), an Oral, Nonpeptide GLP-1 Receptor Agonist

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Volltextzugriff (PDF)

Mechanistic and pharmacological characterization of PF-04457845: a highly potent and selective fatty acid amide hydrolase inhibitor that reduces inflammatory and noninflammatory pain

The Journal of pharmacology and experimental therapeutics, 2011-07, Vol.338 (1), p.114-124

2011

Volltextzugriff (PDF)

Translating Molecules into Medicines: Cross-Functional Integration at the Drug Discovery-Development Interface

1, 2017

Volltextzugriff (PDF)

Modulating target engagement of small molecules via drug delivery: approaches and applications in drug discovery and development

Drug discovery today, 2021-03, Vol.26 (3), p.713-723

2021

Volltextzugriff (PDF)

Solubility measurement of polymorphic compounds via the pH-metric titration technique

International journal of pharmaceutics, 2007-02, Vol.330 (1), p.105-113

2007

Volltextzugriff (PDF)

Effect of Food Consumption on the Pharmacokinetics, Safety, and Tolerability of Once-Daily Orally Administered Orforglipron (LY3502970), a Non-peptide GLP-1 Receptor Agonist

Diabetes therapy, 2024-04, Vol.15 (4), p.819-832

2024

Volltextzugriff (PDF)

Solubility: it's not just for physical chemists

Drug discovery today, 2006-11, Vol.11 (21), p.1012-1018

2006

Volltextzugriff (PDF)

Discovery and Characterization of 2‑Acylaminoimidazole Microsomal Prostaglandin E Synthase‑1 Inhibitors

Journal of medicinal chemistry, 2016-01, Vol.59 (1), p.194-205

2016

Volltextzugriff (PDF)

Discovery and characterization of [(cyclopentyl)ethyl]benzoic acid inhibitors of microsomal prostaglandin E synthase-1

Bioorganic & medicinal chemistry letters, 2017-03, Vol.27 (6), p.1478-1483

2017

Volltextzugriff (PDF)

Characterization of 3,3-dimethyl substituted N-aryl piperidines as potent microsomal prostaglandin E synthase-1 inhibitors

Bioorganic & medicinal chemistry letters, 2016-10, Vol.26 (19), p.4824-4828

2016

Volltextzugriff (PDF)

Evaluation of the chemiluminescent nitrogen detector for solubility determinations to support drug discovery

Journal of pharmaceutical and biomedical analysis, 2006-04, Vol.41 (1), p.152-157

2006

Volltextzugriff (PDF)

Automated approach to couple solubility with final pH and crystallinity for pharmaceutical discovery compounds

Journal of pharmaceutical and biomedical analysis, 2007-04, Vol.43 (5), p.1660-1666

2007

Volltextzugriff (PDF)

Dissolution testing of a poorly soluble compound using the flow-through cell dissolution apparatus

International journal of pharmaceutics, 2002-04, Vol.236 (1), p.135-143

2002

Volltextzugriff (PDF)

Evaluation of the vibratory feeder method for assessment of powder flow properties

International journal of pharmaceutics, 2004-01, Vol.269 (2), p.385-392

2004

Volltextzugriff (PDF)

Increased Dissolution Rate and Bioavailability Through Comicronization with Microcrystalline Cellulose

Pharmaceutical development and technology, 2005-01, Vol.10 (4), p.451-460

2005

Volltextzugriff (PDF)

Discovery and characterization of [(cyclopentyl)ethyl]benzoic acid inhibitors of microsomal prostaglandin E synthase-1

Bioorganic & medicinal chemistry letters, 2017-03, Vol.27 (6)

2017

Volltextzugriff (PDF)

Characterization of 3,3-dimethyl substituted N-aryl piperidines as potent microsomal prostaglandin E synthase-1 inhibitors

Bioorganic & medicinal chemistry letters, 2016-10, Vol.26 (19)

2016

Volltextzugriff (PDF)

Discovery and Characterization of 2-Acylaminoimidazole Microsomal Prostaglandin E Synthase-1 Inhibitors

Journal of medicinal chemistry, 2015-12, Vol.59 (1)

2015

Volltextzugriff (PDF)

In Silico ADME Techniques Used in Early-Phase Drug Discovery

Translating Molecules into Medicines, p.81-117

Volltextzugriff (PDF)

Regulatory Aspects at the Drug Discovery Development Interface

Translating Molecules into Medicines, p.373-388

Volltextzugriff (PDF)

Integrated Lead Optimization: Translational Models as We Advance Toward the Clinic

Translating Molecules into Medicines, p.165-230

Volltextzugriff (PDF)

Discover Toxicology: An Early Safety Assessment Approach

Translating Molecules into Medicines, p.119-162

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(44)

Publikationsform

Sprache

Englisch
(45)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Effect of gastric pH on the pharmacokinetics of a bcs class II compound in dogs: Utilization of an artificial stomach and duodenum dissolution model and gastroplus,™ simulations to predict absorption

Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor

Weak bases and formation of a less soluble lauryl sulfate salt/complex in sodium lauryl sulfate (SLS) containing media

769-P: Effect of Food on the Pharmacokinetics, Safety, and Tolerability of Orforglipron (LY3502970), an Oral, Nonpeptide GLP-1 Receptor Agonist

Mechanistic and pharmacological characterization of PF-04457845: a highly potent and selective fatty acid amide hydrolase inhibitor that reduces inflammatory and noninflammatory pain

Translating Molecules into Medicines: Cross-Functional Integration at the Drug Discovery-Development Interface

Modulating target engagement of small molecules via drug delivery: approaches and applications in drug discovery and development

Solubility measurement of polymorphic compounds via the pH-metric titration technique

Effect of Food Consumption on the Pharmacokinetics, Safety, and Tolerability of Once-Daily Orally Administered Orforglipron (LY3502970), a Non-peptide GLP-1 Receptor Agonist

Solubility: it's not just for physical chemists

Discovery and Characterization of 2‑Acylaminoimidazole Microsomal Prostaglandin E Synthase‑1 Inhibitors

Discovery and characterization of [(cyclopentyl)ethyl]benzoic acid inhibitors of microsomal prostaglandin E synthase-1

Characterization of 3,3-dimethyl substituted N-aryl piperidines as potent microsomal prostaglandin E synthase-1 inhibitors

Evaluation of the chemiluminescent nitrogen detector for solubility determinations to support drug discovery

Automated approach to couple solubility with final pH and crystallinity for pharmaceutical discovery compounds

Dissolution testing of a poorly soluble compound using the flow-through cell dissolution apparatus

Evaluation of the vibratory feeder method for assessment of powder flow properties

Increased Dissolution Rate and Bioavailability Through Comicronization with Microcrystalline Cellulose

Discovery and characterization of [(cyclopentyl)ethyl]benzoic acid inhibitors of microsomal prostaglandin E synthase-1

Characterization of 3,3-dimethyl substituted N-aryl piperidines as potent microsomal prostaglandin E synthase-1 inhibitors

Discovery and Characterization of 2-Acylaminoimidazole Microsomal Prostaglandin E Synthase-1 Inhibitors

In Silico ADME Techniques Used in Early-Phase Drug Discovery

Regulatory Aspects at the Drug Discovery Development Interface

Integrated Lead Optimization: Translational Models as We Advance Toward the Clinic

Discover Toxicology: An Early Safety Assessment Approach

Suchergebnisse filtern